亚太地区肠外营养市场预测至 2030 年 - 区域分析 - 按营养素类型（单剂量氨基酸溶液、肠外脂质乳剂、碳水化合物、微量元素、维生素和矿物质）和最终用户（医院、诊所等）
公司新产品开发推动亚太地区肠外营养市场发展
在肠外医疗营养市场运营的公司不断专注于新产品的推出，这有助于他们提高销量。以下是肠外营养市场的一些值得注意的发展：
2023 年，百特韩国推出了 Olimel N12E，一种富含蛋白质的全肠外营养 (TPN) 液，用于重症患者。
2023 年，JW Holdings 开始通过当地制药公司 AsiaPharma LLC 向蒙古大规模出口三室全肠外营养 (TPN) Winuf Central 736/1,085ml。
因此，预计营养新产品的开发将在预测期内为市场增长创造机会。
亚太肠外营养市场概览
由于人群中幽门螺杆菌感染的患病率不断上升，中国面临着沉重的胃癌负担。世界卫生组织国际癌症研究机构 (IARC) 以及英国和中国的合作机构在 2021 年进行的一项研究发现，幽门螺杆菌感染在中国很普遍。此外，在 30 岁以上的成年人中，62.1% 的贲门胃癌病例和 78.5% 的非贲门胃癌病例的主要原因是幽门螺杆菌感染。 IARC 的这项研究估计，中国每年约有 340,000 例因幽门螺杆菌感染而患上胃癌。根据 2020 年 10 月发布的全球疾病负担研究，胃癌是 2019 年十大死亡原因之一。同样，根据国际癌症研究机构 (IARC) 的最新数据，中国胃癌的年龄标准化发病率估计为每 100,000 人 20.58 人，粗发病率为 33.06。根据同一来源，2020 年男女新发病例 (0-74 岁) 估计数量为 478,508 例。因此，由于上述因素，预测期内，肠外营养市场在中国可能会出现显着增长。
亚太地区肠外营养市场收入及预测至 2030 年（百万美元）
亚太地区肠外营养市场细分
亚太地区肠外营养市场根据营养类型、最终用户和国家/地区进行细分。根据营养类型，亚太地区肠外营养市场分为单剂量氨基酸溶液、肠外脂质乳剂、碳水化合物、微量元素以及维生素和矿物质。单剂量氨基酸溶液部分在 2022 年占据最大市场份额。
按最终用户划分，亚太地区肠外营养市场分为医院、诊所和其他。医院部分在 2022 年占据最大市场份额。
根据国家/地区，亚太地区肠外营养市场分为中国、日本、印度、澳大利亚、韩国和亚太地区其他地区。 2022 年，中国占据了亚太地区肠外营养市场的主导份额。
ICU Medical Inc、Grifols SA、辉瑞公司、大冢制药有限公司、百特国际公司、B Braun SE、Fresenius Kabi AG、Aculife Healthcare Pvt Ltd、四川科伦博泰生物制药有限公司和 Vifor Pharma Management AG 是亚太地区肠外营养市场的一些领先参与者。
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Parenteral Nutrition Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rise in Prevalence of Gastrointestinal Diseases
4.1.2 Surge in Cases of Malnutrition and Premature Births
4.2 Market Restraints
4.2.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Parenteral Feeding Systems
4.3 Market Opportunities
4.3.1 New Product Developments by Companies
4.4 Future Trends
4.4.1 Innovation in Formulations of Nutrition Products
4.5 Impact Analysis
5. Parenteral Nutrition Market - Asia Pacific Market Analysis
5.1 Overview
5.2 Parenteral Nutrition Market Revenue (US$ Mn), 2020 - 2030
6. Asia Pacific Parenteral Nutrition Market Analysis - by Nutrient Type
6.1 Overview
6.2 Single Dose Amino Acid Solution
6.2.1 Overview
6.2.2 Single Dose Amino Acid Solution: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Parenteral Lipid Emulsion
6.3.1 Overview
6.3.2 Parenteral Lipid Emulsion: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Carbohydrates
6.4.1 Overview
6.4.2 Carbohydrates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Trace Elements
6.5.1 Overview
6.5.2 Trace Elements: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Vitamins and Minerals
6.6.1 Overview
6.6.2 Vitamins and Minerals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific Parenteral Nutrition Market Analysis - by End User
7.1 Overview
7.2 Hospitals
7.2.1 Overview
7.2.2 Hospitals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Clinics
7.3.1 Overview
7.3.2 Clinics: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Parenteral Nutrition Market - Country Analysis
8.1 Asia Pacific
8.1.1 Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast Analysis - by Country
8.1.1.1 China: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.1.1 Overview
8.1.1.1.2 China: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.1.3 China: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.1.4 China: Parenteral Nutrition Market Breakdown, by End User
8.1.1.2 Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.2.1 Overview
8.1.1.2.2 Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.2.3 Japan: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.2.4 Japan: Parenteral Nutrition Market Breakdown, by End User
8.1.1.3 India: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.3.1 Overview
8.1.1.3.2 India: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.3.3 India: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.3.4 India: Parenteral Nutrition Market Breakdown, by End User
8.1.1.4 Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.4.1 Overview
8.1.1.4.2 Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.4.3 Australia: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.4.4 Australia: Parenteral Nutrition Market Breakdown, by End User
8.1.1.5 South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.5.1 Overview
8.1.1.5.2 South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.5.3 South Korea: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.5.4 South Korea: Parenteral Nutrition Market Breakdown, by End User
8.1.1.6 Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.6.1 Overview
8.1.1.6.2 Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.6.3 Rest of Asia Pacific: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.6.4 Rest of Asia Pacific: Parenteral Nutrition Market Breakdown, by End User
9. Industry Landscape
9.1 Overview
9.1.1 Overview
10. Company Profiles
10.1 ICU Medical Inc
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Grifols SA
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Pfizer Inc
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Otsuka Pharmaceuticals Co Ltd
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Baxter International Inc
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 B Braun SE
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Fresenius Kabi AG
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Vifor Pharma Management AG
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Aculife Healthcare Pvt Ltd
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Products and Services
10.10.4 Financial Overview
10.10.5 SWOT Analysis
10.10.6 Key Developments
11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
List of Tables
Table 1. Parenteral Nutrition Market Segmentation
Table 2. China: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 3. China: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 4. Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 5. Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 6. India: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 7. India: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 8. Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 9. Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 10. South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 11. South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 12. Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 13. Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 14. Recent Organic Growth Strategies in the Parenteral Nutrition Market
Table 15. Glossary of Terms, Parenteral Nutrition Market
List of Figures
Figure 1. Parenteral Nutrition Market Segmentation, By Country
Figure 2. Parenteral Nutrition Market: Key Industry Dynamics
Figure 3. Parenteral Nutrition Market: Impact Analysis of Drivers and Restraints
Figure 4. Parenteral Nutrition Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Parenteral Nutrition Market Share (%) - by Nutrient Type (2022 and 2030)
Figure 6. Single Dose Amino Acid Solution: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Parenteral Lipid Emulsion: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Carbohydrates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Trace Elements: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Vitamins and Minerals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Parenteral Nutrition Market Share (%) - by End User (2022 and 2030)
Figure 12. Hospitals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Clinics: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Asia Pacific: Parenteral Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
Figure 16. Asia Pacific: Parenteral Nutrition Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 17. China: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 18. Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 19. India: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 20. Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 21. South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 22. Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
1. ICU Medical Inc
2. Grifols SA
3. Pfizer Inc
4. Otsuka Pharmaceuticals Co Ltd
5. Baxter International Inc
6. B Braun SE
7. Fresenius Kabi AG
8. Aculife Healthcare Pvt Ltd
9. Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
10. Vifor Pharma Management AG
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific parenteral nutrition market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific parenteral nutrition market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific parenteral nutrition market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.